Sponsor:
Kyverna Therapeutics
Code:
NCT06193889
Conditions
Myasthenia Gravis
Generalized Myasthenia Gravis
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Standard of Care Treatment
Standard lymphodepletion regimen
KYV-101
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-05-11. This information was provided to ClinicalTrials.gov by Kyverna Therapeutics on 2026-04-06.